Panatuss DXP and Risankizumab
Determining the interaction of Panatuss DXP and Risankizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexbrompheniramine / dextromethorphan / phenylephrine
Brand name: Alahist CF, G-P-Tuss DXP, Panatuss DXP, Supress A Pediatric, Alahist DM, Bionatuss, Supress A, Tussall, Tussall-ER, Dexall, Y-Cof DM, Panatuss Pediatric DXP
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Panatuss DXP-Risankizumab-rzaa topical
- Panatuss DXP-Risedronate
- Panatuss DXP-Risedronate and Calcium
- Panatuss DXP-Risedronate Delayed Release
- Panatuss DXP-Risedronate Delayed-Release Tablets
- Panatuss DXP-Risedronate Sodium
- Risankizumab-Panatuss PED
- Risankizumab-Panatuss PED Drops
- Risankizumab-Pancof HC
- Risankizumab-Pancof XP
- Risankizumab-Pancreatin
- Risankizumab-Pancreatin 4X